TITLE

Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?

AUTHOR(S)
Miller, Robert F.
PUB. DATE
August 2000
SOURCE
Thorax;Aug2000 Supplement 1, Vol. 55, pS15
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
67205601

 

Related Articles

  • Pneumocystis carinii.  // Columbia Electronic Encyclopedia, 6th Edition;Feb2013, p1 

    Pneumocystis carinii: see pneumonia.

  • Pneumocystis carinii.  // Columbia Electronic Encyclopedia, 6th Edition;Q1 2017, p1 

    Pneumocystis carinii: see pneumonia.

  • Dapsone.  // Reactions Weekly;Apr2014, Vol. 1497 Issue 1, p16 

    The article presents a case study of a patient with acute generalised exanthematous pustulosis due to pneumocystis carinii pneumonia prophylaxis using dapsone.

  • Prophylaxis Recommendations for Pneumocystis. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;3/25/2002, Vol. 15 Issue 3, p110 

    Reports the indication of primary prophylaxis of Pneumocystis for patients with history of Pneumocystis carinii pneumonia. Efficacy of trimethoprim-sulfamethoxazole (TMP-SMX); Considerations in discontinuing primary and secondary prophylaxis; Dosage for TMP-SMX.

  • PCP Prophylaxis in Perinatally HIV-Exposed Infant. Shahid, Sukhbir Kaur // Indian Pediatrics;Nov2008, Vol. 45 Issue 11, p939 

    A letter to the editor is presented about the recommendations for cotrimoxazole Pneumocystis carinii pneumonia (PCP) prophylaxis in perinatally human immunodeficiency virus (HIV)-exposed babies.

  • PCP Prophylaxis in Perinatally HIV-Exposed Infant. Tullu, Milind S. // Indian Pediatrics;Nov2008, Vol. 45 Issue 11, p939 

    A response to a letter to the editor about the recommendations for cotrimoxazole Pneumocystis carinii pneumonia (PCP) prophylaxis in perinatally human immunodeficiency virus (HIV)-exposed babies is presented.

  • Discontinuing Prophylaxis against Pneumocystis carinii Pneumonia. Le Moal, GwenaĆ«l; Breux, Jean-Philippe; Roblot, France // New England Journal of Medicine;05/24/2001, Vol. 344 Issue 21, p1639 

    A letter to the editor is presented about cases of Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis after a positive response to antiretroviral therapy.

  • Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Blanchet, Kevin D. // AIDS Patient Care & STDs;Apr96, Vol. 10 Issue 2, p116 

    Presents a dialogue on current management practices in the treatment of Pneumocystis carinii pneumonia (PCP). Prophylaxis and compliance; Treatment of mild PCP; Patient management issues.

  • LESS FREQUENT TMP-SMX IS EFFECTIVE.  // AIDS Patient Care & STDs;Feb2000, Vol. 14 Issue 2, p104 

    Reports on research findings at Harlem Hospital in New York City that the frequency of dosing of TMP-SMX for prophylaxis of pneumocystis carinii pneumonia (PCP).

  • Determinants of Antimicrobial Prophylaxis Use and Treatment for Wasting among Patients with Advanced Human Immunodeficiency Virus Disease in the United States, 1995-1998. Murphy, Edward L.; Assmann, Susan F.; Collier, Ann C.; Flanigan, Timothy P.; Kumar, Princy N.; Wallach, Fran R.; Krubel, Sharon // Clinical Infectious Diseases;1/1/2001, Vol. 32 Issue 1, p116 

    Discusses a study which measured the prevalence of antimicrobial prophylaxis use and treatment for HIV wasting among patients with advanced HIV. Characteristics of the patients; Data and methodology; Prophylaxis for pneumocystis carinii pneumonia and mycobacterium avium complex.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics